A0384 TGF-β inhibition upregulates Nectin-4 surface expression and enhances enfortumab vedotin efficacy in urothelial carcinoma

European Urology 2026

View at publisher

Authors: A. Heselich, Eduard Below, E. Tan, Abdullah Alajati, M. Ritter, M. Toma, M. Eckstein, N. Klümper, M. Hölzel

DOI: 10.1016/s0302-2838(26)00439-2

Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments TGF-β signaling in diseases Cancer Immunotherapy and Biomarkers